Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 1.19 is 53% above its 5-year average of 0.78, near the low end of its 5-year range (0.06–10.93).
As of the fiscal period ended Tuesday, June 30, 2026. 37.95% above its 12-month average of 0.86.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.19.
CURRENT RATIO
1.19
CURRENT RATIO AVG TTM
0.86
CURRENT RATIO AVG 3Y
0.42
CURRENT RATIO AVG 5Y
0.78
CURRENT RATIO AVG 10Y
0.85
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
+37.95%
CURRENT VS 3Y AVG
+185.08%
CURRENT VS 5Y AVG
+52.71%
CURRENT VS 10Y AVG
+40.14%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.59
median of 792 covered companies
CURRENT VS SECTOR MEDIAN
-66.94%
vs the sector median at left
Market Cap
$17.01M
Current Ratio
6.03
TTM Avg
7.38
3Y Avg
5.62
5Y Avg
4.97
Market Cap
$16.73M
Current Ratio
4.61
TTM Avg
2.49
3Y Avg
1.77
5Y Avg
2.58
Market Cap
$18.65M
Current Ratio
27.85
TTM Avg
15.71
3Y Avg
9.25
5Y Avg
10.43
Market Cap
$16.40M
Current Ratio
1.65
TTM Avg
3.34
3Y Avg
3.94
5Y Avg
7.05
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| PAVmed Inc. (PAVM) | $16.98M | 1.19 | 0.86 | 0.42 | 0.78 |
| Cosmos Health Inc. (COSM)vs › | $17.73M | 1.05 | 0.99 | 1.52 | 1.43 |
| Lipocine Inc. (LPCN)vs › | $17.23M | 11.48 | 10.71 | 12.62 | 10.43 |
| Marker Therapeutics, Inc. (MRKR)vs › | $17.01M | 6.03 | 7.38 | 5.62 | 4.97 |
| Bionano Genomics, Inc. (BNGO)vs › | $16.70M | 2.48 | 1.52 | 2.21 | 4.42 |
| Palatin Technologies, Inc. (PTN)vs › | $16.73M | 4.61 | 2.49 | 1.77 | 2.58 |
| Neuphoria Therapeutics Inc. (NEUP)vs › | $18.65M | 27.85 | 15.71 | 9.25 | 10.43 |
| Dyadic International, Inc. (DYAI)vs › | $16.40M | 1.65 | 3.34 | 3.94 | 7.05 |
| NextCure, Inc. (NXTC)vs › | $18.95M | 3.47 | 5.82 | 11.50 | 18.06 |
| BioCardia, Inc. (BCDA)vs › | $16.00M | 2.09 | 1.13 | 1.21 | 2.30 |
Current Ratio
1.19
Quick Ratio
1.19
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 1.19 |
| 2026-03-31 | 2.02 |
| 2025-12-31 | 0.17 |
| 2025-09-30 | 0.40 |
| 2025-06-30 | 0.52 |
| 2025-03-31 | 0.37 |
| 2024-12-31 | 0.06 |
| 2024-09-30 | 0.06 |
| 2024-06-30 | 0.57 |
| 2024-03-31 | 0.54 |
| 2023-12-31 | 0.45 |
| 2023-09-30 | 0.60 |
| 2023-06-30 | 0.85 |
| 2023-03-31 | 1.07 |
| 2022-12-31 | 1.07 |
| 2022-09-30 | 1.48 |
| 2022-06-30 | 1.82 |
| 2022-03-31 | 4.06 |
| 2021-12-31 | 10.93 |
| 2021-09-30 | 5.38 |
| 2021-06-30 | 8.69 |
| 2021-03-31 | 15.17 |
| 2020-12-31 | 0.94 |
| 2020-09-30 | 0.39 |
| 2020-06-30 | 0.38 |
| 2020-03-31 | 0.36 |
| 2019-12-31 | 0.55 |
| 2019-09-30 | 0.64 |
| 2019-06-30 | 0.78 |
| 2019-03-31 | 0.43 |
| 2018-12-31 | 0.77 |
| 2018-09-30 | 1.60 |
| 2018-06-30 | 2.38 |
| 2018-03-31 | 2.97 |
| 2017-12-31 | 0.64 |
| 2017-09-30 | 0.43 |
| 2017-06-30 | 0.04 |
| 2017-03-31 | 0.20 |
| 2016-12-31 | 0.62 |
| 2016-09-30 | 2.33 |
| 2016-06-30 | 7.78 |
| 2016-03-31 | 0.39 |
| 2015-12-31 | 1.34 |
| 2015-09-30 | 5.93 |
| 2015-06-30 | 6.17 |
| 2015-03-31 | 18.70 |
